Abstract |
Sixty-one consecutive patients in the Intensive Care Unit requiring central venous lines (CVC) for five or more days were randomized to receive either a standard triple lumen CVC (STD/CVC) or a silver sulphadiazine and chlorhexidine impregnated CVC ( SSD/CVC). Data from the 54 patients who completed the trial show a reduced infection rate (positive tip culture) in the SSD/CVC group (4 out of 28) compared to the STD/CVC group (10 out of 26) (P < 0.05). In addition, the new Fibrin Analysing System (FAS) brush was evaluated and used to determine the presence of infection in all the CVCs (STD/CVC and SSD/CVC combined, n = 54) at day 3 (i.e. early warning of CVC colonization/ infection) and at the time of removal of the CVC. The FAS brush was able to detect an infected CVC on only one occasion on day 3 out of the 14 CVC tips which were later found to be colonized/infected at the time of removal. The sensitivity of the FAS brush in detecting colonized/infected CVCs at the time of CVC removal compared with CVC tip culture was 21% with a specificity of 100%. These findings would currently not support the routine use of the FAS brush in determining CVC infection/colonization.
|
Authors | P V van Heerden, S A Webb, S Fong, C L Golledge, B L Roberts, W R Thompson |
Journal | Anaesthesia and intensive care
(Anaesth Intensive Care)
Vol. 24
Issue 3
Pg. 330-3
(Jun 1996)
ISSN: 0310-057X [Print] United States |
PMID | 8805887
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Infective Agents, Local
- Chlorhexidine
- Silver Sulfadiazine
|
Topics |
- Acinetobacter
(isolation & purification)
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Infective Agents, Local
(therapeutic use)
- Bacterial Infections
(etiology, prevention & control)
- Catheterization, Central Venous
(adverse effects, instrumentation)
- Chlorhexidine
(therapeutic use)
- Equipment Design
- Female
- Humans
- Intensive Care Units
- Male
- Middle Aged
- Silver Sulfadiazine
(therapeutic use)
- Staphylococcus epidermidis
(isolation & purification)
|